UnitedHealth Group's Q2 2016 earnings transcript shows strong growth across all segments, particularly Optum, but also highlights significant losses in the ACA exchange market.  While management emphasizes a commitment to shareholder returns and long-term growth, the substantial exchange market losses will likely be a near-term concern for investors, potentially impacting the stock's price negatively over the next few weeks.
[-1]
